A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data

Statistics in Medicine

Volumn 23, Issue 7, 2004, Pages 1075-1093

  Moodie, Patricia F ^a   Nelson, Norma A ^b   Koch, Gary G ^c  

^a UNIVERSITY OF WINNIPEG   (Canada)

^b University of North Carolina ^*  (United States)

^c IL   (United States)

Author keywords

Clinical trials; Hazard ratio; Log( log (survival function); Meta analysis; Proportional hazards; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; ARTIFACT; CLINICAL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; DATA ANALYSIS; EVALUATION; FEASIBILITY STUDY; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HYPOTHESIS; META ANALYSIS; METHODOLOGY; RISK ASSESSMENT; SAMPLE SIZE; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT OUTCOME;

CLINICAL TRIALS; HEAD AND NECK NEOPLASMS; HUMANS; META-ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1842780819     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1696     Document Type: Article

References (43)

1. Begg C. The role of meta-analysis in monitoring clinical trials. Statistics in Medicine 1996; 15:1299-1306.
2. Dersimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7:177-188.
3. Emerson JD, Hoaglin DC, Mosteller F. Simple robust procedures for combining risk differences in sets of 2 × 2 tables. Statistics in Medicine 1996; 15:1465-1488.
4. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard V, Mantel N, McPherson K, Peto J, Smith PG. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer 1977; 35:1-39.
5. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Statistics in Medicine 1991; 10:1665-1677.
6. Dear KBG. Iterative generalized least squares for meta-analysis of survival data at multiple times. Biometrics 1994; 50:989-1002.
7. Marubini E, Valsecchi MG. Analysing Survival Data from Clinical Trials and Observational Studies. Wiley: Chichester, 1995; 1-414.
8. Caubet JF, Tosteson TD, Dong EW, Naylon EM, Whiting GW, Ernstoff MS, Ross SD. Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens. Urology 1997; 49(1):71-78.
9. El-Sayed S, Neslon N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomized trials. Journal of Clinical Oncology 1996; 14:838-847.
10. Shore T, Nelson N, Weinerman B. A meta-analysis of Stages I and II Hodgkin's disease. Cancer 1990; 5: 1155-1160.
11. Feinstein AR. Indexes of contrast and quantitative significance for comparisons of two groups. Statistics in Medicine 1999; 18:2557-2581.
12. D'Agostino RB. Editorial: quantifying the comparison of two groups. Statistics in Medicine 1999; 18: 2551-2555.
13. Koch GG. Discussion for 'indexes of contrast and quantitative significance for comparisons of two groups'. Statistics in Medicine 1999; 18(19):2585-2589.
14. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. Journal of Chronic Diseases 1958; 8:699-712.
15. Greenwood M. The natural duration of cancer. Reports on Public Health and Medical Subjects, vol. 33. Her Majesty's Stationary Office: London, 1926; 1-26.
16. Dorey FJ, Korn EL. Effective sample sizes for confidence intervals for survival probabilities. Statistics in Medicine 1987; 6:679-687.
17. Meier P. Estimation of a distribution function from incomplete observations. In Perspectives in Probability and Statistics, Gant J (ed.). Academic Press: London, 1975; 67-87.
18. Kalbfleisch JD. Prentice RL. The Statistical Analysis of Failure Time Data. Wiley: New York, 1980; 14-15.
19. Barber S, Jennison C. Symmetric tests and confidence intervals for survival probabilities and quantiles of censored survival data. Biometrics 1999; 55:430-436.
20. Chalmers TC, Smith Jr H, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A. A method for assessing the quality of a randomized control trial. Controlled Clinical Trials 1981; 2:31-49.
21. Tritchler D. Modelling study quality in meta-analysis. Statistics in Medicine 1999; 18:2135-2145.
22. Hedges L, Olkin I. Statistical Methods for Meta-analysis. Academic Press: San Diego, 1985.
23. Greenland S. Invited commentary: a critical look at some popular meta-analytic methods. American Journal of Epidemiology 1994; 140:290-301.
24. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10:101-129.
25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959; 22:719-748.
26. Matt GE, Cook TD. Threats to the validity of research syntheses. In The Handbook of Research Synthesis, Cooper H, Hedges LV (eds), Russell Sage Foundation: New York, 1994; 501-502.
27. Abe M, Shigematsu Y, Kimura S. Combined use of bleomycin with radiation in the treatment of cancer. Recent Results Cancer Research 1978; 63:169-178.
28. Fu KK, Phillips TL, Silverberg IJ, Jacobs C, Goffinet DR, Chun C, Friedman MA, Kohler M, McWhirter K, Carter SK. Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. Journal of Clinical Oncology 1987; 5:1410-1418.
29. Bezwoda WR, de Moor NG, Derman DP. Treatment of advanced head and neck cancer by means of radiation therapy plus chemotherapy - a randomised trial. Medical and Pediatric Oncology 1979; 6:353-358.
30. Pearlman NW, Johnson FB, Braun TJ, Kennaugh RC, Spofford BF, Borlase BC, Meyer TJ, Stiegmann GV, Meyers AD. A prospective study of preoperative chemotherapy and split-course irradiation for locally advanced or recurrent oral/pharyngeal squamous carcinoma. American Journal of Clinical Oncology (CCT) 1985; 8: 490-496.
31. Shigematsu Y, Sakai S, Fuchihata H. Recent trials in the treatment of maxillary sinus carcinoma with special reference to the chemical potentiation of radiation therapy. Acta Laryngologica 1971; 71:63-70.
32. Vermund H, Kaalhus O, Winther F, Trausjo J, Thorud E, Harang R. Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. International Journal of Radiation Oncology, Biology, Physics 1985; 11:1877-1886.
33. Gupta NK, Pointon RCS, Wilkinson PM. A randomised clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clinical Radiology 1985; 38:575-581.
34. Parvinen L-M, Parvinen M, Nordman E, Kortekangas AE. Combined bleomycin treatment and radiation therapy in squamous cell carcinoma of the head and neck region. Acta Radiologica Oncology 1985; 24:487-489.
35. Ansfield FJ, Ramirez G, Davis Jr HL, Korbitz BC, Vermund H, Gollin FF. Treatment of advanced cancer of the head and neck. Cancer 1970; 25:78-82.
36. Weissberg JB, Son YH, Papac RJ, Sasaki C, Fischer DB, Lawrence R, Rockwell S, Sartorelli AC, Fischer JJ. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. International Journal of Radiation, Oncology, Biology, and Physics 1989; 17:3-9.
37. Cachin Y, Jortay A, Sancho H, Eschwege F, Madelain M, Desaulty A, Gerard P. Preliminary results of a randomized E.O.R.T.C. study comparing radiotherapy and complimentary bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx. European Journal of Cancer 1977; 13:1389-1395.
38. Lee ET. Statistical Methods for Survival Data Analysis. Wiley: New York, 1993.
39. Elandt-Johnson RC, Johnson NL. Survival Models and Data Analysis. Wiley: New York, 1980; 156.
40. Stell PM, Rawson NSB. Adjuvant chemotherapy in head and neck cancer. British Journal of Cancer 1990; 61:779-787.
41. Kendall MG, Stuart A. The Advanced Theory of Statistics, vol. 1. Charles Griffin and Company: London, 1958.
42. Koch GG, Johnson WD, Tolley HD. A linear models approach to the analysis of survival and extent of disease in multidimensional contingency tables. Journal of the American Statistical Association 1972; 67(340): 783-796.
43. Stokes ME, Davis CS, Koch GG. Chapter 17: Categorized time-to-event data. In Categorical Data Analysis Using the SAS System (2nd edn). SAS Institute, Inc.: Cary, 1991; 591-605.